2 days Bank of America Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $541.00MarketBeat
Bank of America reduced their target price on shares of Vertex Pharmaceuticals from $550.00 to $541.00 and set a “buy” rating on the stock in a research note on Monday.
Bank of America (BAC) · Nasdaq 100 · Pharmaceuticals · Science · Vertex (VRTX)
X